Alnylam Pharmaceuticals
Lawrence Egan possesses extensive experience in the pharmaceutical and technology sectors, currently serving as the Vice President of Strategic Technologies at Alnylam Pharmaceuticals since February 2019. Prior roles at Alnylam include Senior Director of Global Commercial Systems and experience at Alexion Pharmaceuticals as Senior Director of Global Business Operations. Lawrence's tenure at Purdue Pharma spanned over 16 years, where responsibilities included Executive Director of Commercial, HR & Financial Systems. Prior to these positions, Lawrence held roles at Diversified Investment Advisors and Pepsi Cola North America, focusing on IT technical functions and infrastructure services, respectively. Academic credentials include an M.B.A. in Finance from Sacred Heart University and a Bachelor's Degree in Management Information Systems from Western Connecticut State University.
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.